Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Duda

Showing results (121-130 of 222) with videos related to

Pageof 23
Sort By:
Parkinsonism & Related Disorders|June 12, 2013
Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's diseaseLama M Chahine, Joseph Daley, Stacy Horn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2007
Long-term follow-up of impulse control disorders in Parkinson's diseaseEugenia Mamikonyan, Andrew D Siderowf, John E Duda, et al.
Neuron|June 14, 2002
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synucleinBenoit I Giasson, John E Duda, Shawn M Quinn, et al.
Journal of Neuroscience Research|February 19, 2000
A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's diseaseB I Giasson, R Jakes, M Goedert, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 13, 2002
Kupffer cell phagocytosis blockade decreases morbidity in endotoxemic rats with obstructive jaundiceG Lázár, A Paszt, J Kaszaki, et al.
Neurology|November 26, 2009
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson diseaseS Hoops, S Nazem, A D Siderowf, et al.
Neurology|July 20, 2014
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyKimberly Papay, Sharon X Xie, Matthew Stern, et al.
Parkinsonism & Related Disorders|April 6, 2019
Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but 'failure to fit' is highly dependent on staging system appliedDavid G Coughlin, Helen Petrovitch, Lon R White, et al.
International Immunopharmacology|January 24, 2006
Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytesK Kis, L Bodai, H Polyanka, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|November 13, 2013
Lower urinary tract symptoms in men with Parkinson diseaseJoanne P Robinson, Christine W Bradway, Lisette Bunting-Perry, et al.
Pageof 23

Showing results (121-130 of 222) with videos related to

Sort By:
Pageof 23
Parkinsonism & Related Disorders|June 12, 2013
Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's diseaseLama M Chahine, Joseph Daley, Stacy Horn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2007
Long-term follow-up of impulse control disorders in Parkinson's diseaseEugenia Mamikonyan, Andrew D Siderowf, John E Duda, et al.
Neuron|June 14, 2002
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synucleinBenoit I Giasson, John E Duda, Shawn M Quinn, et al.
Journal of Neuroscience Research|February 19, 2000
A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's diseaseB I Giasson, R Jakes, M Goedert, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|December 13, 2002
Kupffer cell phagocytosis blockade decreases morbidity in endotoxemic rats with obstructive jaundiceG Lázár, A Paszt, J Kaszaki, et al.
Neurology|November 26, 2009
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson diseaseS Hoops, S Nazem, A D Siderowf, et al.
Neurology|July 20, 2014
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyKimberly Papay, Sharon X Xie, Matthew Stern, et al.
Parkinsonism & Related Disorders|April 6, 2019
Most cases with Lewy pathology in a population-based cohort adhere to the Braak progression pattern but 'failure to fit' is highly dependent on staging system appliedDavid G Coughlin, Helen Petrovitch, Lon R White, et al.
International Immunopharmacology|January 24, 2006
Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytesK Kis, L Bodai, H Polyanka, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|November 13, 2013
Lower urinary tract symptoms in men with Parkinson diseaseJoanne P Robinson, Christine W Bradway, Lisette Bunting-Perry, et al.
Pageof 23